2020

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

HAI Follows Dutch Government Advice in Response to COVID-19

2018

What Role Can Civil Society Play in the European Regulatory Process?

Open Science for Health: Shaping the New Framework Programme

2017

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

2016

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

2015

HAI urges MEPs to support key amendments to TTIP resolution

The EU-US Trade Deal Could Leave Europeans Sick

2014

EMA policy on clinical data publication a step ahead, but falls short of true potential

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

2011

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

2010

Report exposes how Big Pharma has hijacked EU-India trade deal

HAI hosts essay competition for students